MX2008015059A - Formulaciones de sal prednisolona. - Google Patents

Formulaciones de sal prednisolona.

Info

Publication number
MX2008015059A
MX2008015059A MX2008015059A MX2008015059A MX2008015059A MX 2008015059 A MX2008015059 A MX 2008015059A MX 2008015059 A MX2008015059 A MX 2008015059A MX 2008015059 A MX2008015059 A MX 2008015059A MX 2008015059 A MX2008015059 A MX 2008015059A
Authority
MX
Mexico
Prior art keywords
tablets
sodium phosphate
prednisolone sodium
phosphate formulations
odts
Prior art date
Application number
MX2008015059A
Other languages
English (en)
Inventor
Walid Habib
Kothari Bhareshkumar
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/638,260 external-priority patent/US20070281014A1/en
Priority claimed from US11/638,216 external-priority patent/US8637076B2/en
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of MX2008015059A publication Critical patent/MX2008015059A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a los comprimidos que contienen sales de prednisolona, y en particular, fosfato de sodio de prednisolona. Los comprimidos incluyen ODT y no-ODT, comprimidos efervescentes y no efervescentes, y comprimidos que reúnen ciertos criterios de funcionamiento.
MX2008015059A 2006-06-01 2007-05-30 Formulaciones de sal prednisolona. MX2008015059A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81001506P 2006-06-01 2006-06-01
US11/638,260 US20070281014A1 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
US11/638,216 US8637076B2 (en) 2006-06-01 2006-12-13 Prednisolone salt formulations
PCT/US2007/013008 WO2007143131A2 (en) 2006-06-01 2007-05-30 Prednisolone sodium phosphate formulations

Publications (1)

Publication Number Publication Date
MX2008015059A true MX2008015059A (es) 2009-04-14

Family

ID=38616310

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2008015059A MX2008015059A (es) 2006-06-01 2007-05-30 Formulaciones de sal prednisolona.
MX2008015058A MX2008015058A (es) 2006-06-01 2007-05-31 Formulaciones de sal de prednisolona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2008015058A MX2008015058A (es) 2006-06-01 2007-05-31 Formulaciones de sal de prednisolona.

Country Status (3)

Country Link
CA (2) CA2653485A1 (es)
MX (2) MX2008015059A (es)
WO (2) WO2007143131A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926722B1 (fr) * 2008-01-25 2010-09-03 Substipharm Dev Formulation pharmaceutique appropriee pour la preparation de comprimes orodispersibles de prednisolone

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615854A (es) *
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
JP2002530322A (ja) * 1998-11-25 2002-09-17 シーマ・ラブス・インコーポレイテッド 味隠蔽迅速放出コーティング系
CA2470859A1 (en) * 2001-12-20 2003-07-03 Alpex Pharma Sa Pharmaceutical composition comprising skim milk powder
AU2003300469A1 (en) * 2002-12-31 2004-07-29 Larry L. Augsburger Methods for making pharmaceutical dosage forms containing active cushioning components
RU2382637C2 (ru) * 2004-04-30 2010-02-27 Астеллас Фарма Инк. Фармацевтическая композиция для перорального введения в форме частиц с рассчитанным временем высвобождения и быстро распадающиеся таблетки, содержащие указанную композицию

Also Published As

Publication number Publication date
WO2007143061A2 (en) 2007-12-13
WO2007143131A2 (en) 2007-12-13
WO2007143131A3 (en) 2008-03-20
CA2653485A1 (en) 2007-12-13
WO2007143061A3 (en) 2008-02-14
CA2653480A1 (en) 2007-12-13
MX2008015058A (es) 2009-04-14
WO2007143131A9 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
WO2007064885A3 (en) Oral care compositions, methods, devices and systems
MX2009013338A (es) Sistemas de perfume.
MX2009012690A (es) Composiciones, metodos, dispositivos y sistemas para el cuidado bucal.
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
HUP0600027A3 (en) Antiseptic compositions, methods and systems
MX2009007254A (es) Composiciones de tableta en tableta.
WO2010002586A3 (en) Topical compositions comprising isonicotinamide
MX2010008932A (es) Composiciones limpiadoras.
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
TW200618817A (en) Diffractive colorants for cosmetics
MY160456A (en) Benzodiazepine bromodomain inhibitor
GB0415219D0 (en) Improvements in or relating to time-of-flight ranging systems
MX349787B (es) Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
GB0404857D0 (en) Improvements in or relating to time-of-flight ranging systems
WO2008089397A3 (en) Adrb2 cancer markers
WO2009077471A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2007017176A8 (en) Wound-healing composition
MX2009007389A (es) Composiciones paras el cuidado oral que comprende extracto de hippophae.
TW200942530A (en) Pyridine compounds
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
TW200700071A (en) Novel use
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
GB0902937D0 (en) Composition

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration